Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Change in Acquisitions & Divestments (2022 - 2025)

Entrada Therapeutics has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $47.4 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $47.4 million for Q4 2025, down 60.01% from a year ago — trailing twelve months through Dec 2025 was $259.5 million (down 37.19% YoY), and the annual figure for FY2025 was $259.5 million, down 37.19%.
  • Change in Acquisitions & Divestments for Q4 2025 was $47.4 million at Entrada Therapeutics, down from $75.5 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for TRDA hit a ceiling of $123.9 million in Q1 2024 and a floor of $1.7 million in Q1 2022.
  • Median Change in Acquisitions & Divestments over the past 4 years was $68.8 million (2023), compared with a mean of $63.9 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 3575.61% in 2023 and later plummeted 60.01% in 2025.
  • Entrada Therapeutics' Change in Acquisitions & Divestments stood at $19.5 million in 2022, then soared by 456.62% to $108.5 million in 2023, then increased by 9.17% to $118.5 million in 2024, then plummeted by 60.01% to $47.4 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $47.4 million (Q4 2025), $75.5 million (Q3 2025), and $50.6 million (Q2 2025) per Business Quant data.